These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 12187169)

  • 1. Utility of the SEER-Medicare data to identify chemotherapy use.
    Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
    Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying specific chemotherapeutic agents in Medicare data: a validation study.
    Lund JL; Stürmer T; Harlan LC; Sanoff HK; Sandler RS; Brookhart MA; Warren JL
    Med Care; 2013 May; 51(5):e27-34. PubMed ID: 22080337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying radiation therapy using SEER-Medicare-linked data.
    Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
    Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of SEER Treatment Data With Medicare Claims.
    Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
    Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
    Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
    Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining care provided for breast cancer based on medical record review or Medicare claims: information from the Centers for Disease Control and Prevention Patterns of Care Study.
    Fleming ST; Kimmick GG; Sabatino SA; Cress RD; Wu XC; Trentham-Dietz A; Huang B; Hwang W; Liff JM;
    Ann Epidemiol; 2012 Nov; 22(11):807-13. PubMed ID: 22948184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the SEER-Medicare Data.
    Warren JL; Parsons HM; Mariotto AB; Boyd E; Enewold L
    Med Care; 2023 Dec; 61(12):846-857. PubMed ID: 37796197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of SEER-Medicare data for measuring cancer surgery.
    Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring complications of cancer treatment using the SEER-Medicare data.
    Potosky AL; Warren JL; Riedel ER; Klabunde CN; Earle CC; Begg CB
    Med Care; 2002 Aug; 40(8 Suppl):IV-62-8. PubMed ID: 12187170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
    Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
    Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
    Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
    Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of Medicare claims data for measuring cancer stage.
    Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
    Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data.
    Huepenbecker SP; Zhao H; Sun CC; Fu S; He W; Giordano SH; Meyer LA
    JCO Clin Cancer Inform; 2022 Mar; 6():e2100187. PubMed ID: 35297648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of electronic data on chemotherapy and hormone therapy use in HMOs.
    Ritzwoller DP; Carroll N; Delate T; O'Keeffe-Rossetti M; Fishman PA; Loggers ET; Aiello Bowles EJ; Elston-Lafata J; Hornbrook MC
    Med Care; 2013 Oct; 51(10):e67-73. PubMed ID: 22531648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data sources for measuring colorectal endoscopy use among Medicare enrollees.
    Schenck AP; Klabunde CN; Warren JL; Peacock S; Davis WW; Hawley ST; Pignone M; Ransohoff DF
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2118-27. PubMed ID: 17932360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
    Lin CC; Virgo KS
    Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construct validity of medicare chemotherapy claims: the case of 5FU.
    Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
    Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.